Sign in

CIK 0000872589 · Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
133444607
Phone
9148477000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$51,901,544
in 11 filings, $8.6M under 10b5-1 plans

Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SING GEORGE L −$20.4M Director sold 46% of stake
  2. POON CHRISTINE A −$7.6M Director sold 60% of stake
  3. Zoghbi Huda Y −$7.2M Director sold 81% of stake
  4. LAROSA JOSEPH J −$4.3M EVP General Counsel and Secret sold 10% of stake
  5. Pitofsky Jason −$3.8M SVP Controller sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-11 YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO Option exercise +25,155 765,327
2023-12-11 YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO Shares withheld for taxes −12,841 $844.09 $10.8M 752,486
2023-12-11 YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO Option exercise · 2019 Performance Stock Units −25,155 0
2023-12-11 SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO Option exercise +25,155 387,270
2023-12-11 SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO Shares withheld for taxes −12,841 $844.09 $10.8M 374,429
2023-12-11 SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO Option exercise · 2019 Performance Stock Units −25,155 0
2023-12-11 LAROSA JOSEPH J EVP General Counsel and Secret Shares withheld for taxes −669 $844.09 $565K 30,036
2023-12-11 Landry Robert E EVP Finance CFO Shares withheld for taxes −669 $844.09 $565K 30,017
2023-12-11 Landry Robert E EVP Finance CFO Shares withheld for taxes −2,552 $844.09 $2.2M 27,465
2023-12-11 Fenimore Christopher R. SVP Controller Shares withheld for taxes −1,276 $844.09 $1.1M 21,562
2023-12-11 Fenimore Christopher R. SVP Controller Shares withheld for taxes −260 $844.09 $219K 21,302
2023-12-11 Van Plew Daniel P EVP & General Mgr, Industrial Shares withheld for taxes −2,552 $844.09 $2.2M 21,047
2023-12-11 Van Plew Daniel P EVP & General Mgr, Industrial Shares withheld for taxes −669 $844.09 $565K 20,378
2023-12-11 STAHL NEIL EVP Research and Development Shares withheld for taxes −725 $844.09 $612K 52,019
2023-12-11 MURPHY ANDREW J EVP Research Shares withheld for taxes −5,105 $844.09 $4.3M 56,632
2023-12-11 MURPHY ANDREW J EVP Research Shares withheld for taxes −669 $844.09 $565K 55,963
2023-12-11 McCourt Marion EVP Commercial Sale 10b5-1 −270 $838.44 $226K 20,814
2023-12-11 McCourt Marion EVP Commercial Shares withheld for taxes 10b5-1 −373 $844.09 $315K 20,441
2023-12-08 LAROSA JOSEPH J EVP General Counsel and Secret Shares withheld for taxes −852 $843.79 $719K 28,572
2023-12-08 LAROSA JOSEPH J EVP General Counsel and Secret Grant or award +2,133 30,705

Page 44 of 49 · 971 trades